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Neoadjuvant radiotherapy (NeoRT) improves tumor local control and tumor resection in many cancers. The timing between the end of the NeoRT and surgery is driven by the occurrence of side effects or the 
tumor downsizing. Some studies demonstrated that the timing of surgery and the RT schedule could influence tumor dissemination and subsequently patient overall survival (1). Our aim is to evaluate with 
functional MRI the impact of the radiation treatment on the tumor microenvironment and subsequently to determine the best timing to perform surgery avoiding tumor spreading. 
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Acquisition were made on an Agilent 9,4 T MRI with a 40mm diameter volume coil.  
Diffusion Weighted (DW) and Dynamic Contrast Enhancement (DCE) -MRI were performed every 2 days during 11 days between neo-RT and surgery.  
We developed a homemade “portacath (PAC)” specifically dedicated for mice and for repetitive IV gadolinium contrast agent injection.  
For DW-MRI, we performed FSEMS (Fast Spin Echo MultiSlice) sequences, with 10 different B-values (form 20 to 1000) and B0, in the 3 main directions.  
For DCE-MRI, we used FSEMS sequence for keeping the same as with DW-MRI. After the T1 mapping, we performed DCE acquisition with a temporal resolution of 5.6 sec. After 10 repetitions, we injected 100 
µl of gadopentetate dimeglumine (0.1 mmol/kg) in 5 sec. via the PAC and recorded the 190 following repetitions during 14 min. for the contrast enhancement and wash out.  
For both images, we performed analysis on the entire tumor volume and we obtained the mean tumor signal. 
For DW-MRI, we perform IVIM (intra voxel incoherent motion (2)) analysis. With IVIM analysis, we use a biexponential analysis to obtain 3 parameters:     
 D, the true diffusion 
 D*, the pseudo-diffusion 
 F, the perfusion fraction                            
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1) Control VS irradiated 3)Signa  Evolution in irradiated mice 2) Signal Evolution in control mice 
The signal intensity differences between irradiated and 
non irradiated mice could be due to cell death. 
These graphs represent individual mice measurements in 
the irradiated mice. we can observe significative 
difference between the first days and day 8. The 
difference are more in relation with the perfusion (D* and 
F) than the pure diffusion (D) 
The first aim of the study was to demonstrate the protocol feasability of longitudinal following of the tumor microenvironment with DW-MRI after neoadjuvant radiotherapy. 
Here, we succed to follow irradiated mice during 11 days after irradiation with DW-MRI and demonstrades differences in DW-MRI Signal between control and irradiated mice for all the parameters (ADC, D, D* 
and F). We showed in the irradiated group, significative difference in the perfusion related factor betwee day 1 (just after the end of radiotherapy) and day 8. Theses observations could be related to cell death. 
We failed to obtain good DCE data (data not showed). 
The next step will be to correlate functionnal imaging study with neoadjuvant radiotherapy and the risk of tumor dissemination at the time of surgery and following the radiotherapy protocol. 
These graphs represent individual mice measurements in 
the control group. No differences between mice and no 
evolution in time. 
References 
1.Coucke, P. a et al. Effect of timing of surgery on survival after preoperative 
hyperfractionated accelerated radiotherapy (HART) for locally advanced rectal cancer 
(LARC): is it a matter of days? Acta Oncol. 45, 1086–93 (2006). 
2.Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, L.-J. M. Separation of 
diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168, 
566–567 (1988).  
 
